To hear about similar clinical trials, please enter your email below

Trial Title: Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer

NCT ID: NCT06364748

Condition: Hypertension

Conditions: Official terms:
Hypertension

Study type: Interventional

Study phase: N/A

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Supportive Care

Masking: None (Open Label)

Intervention:

Intervention type: Device
Intervention name: Cellular enabled blood pressure cuff
Description: Smart cuff
Arm group label: Smart Cuff Group

Intervention type: Device
Intervention name: Standard of Care Cuff
Description: Standard blood pressure cuff
Arm group label: Control Group

Summary: A randomized trial of remote blood pressure monitoring, compared to usual care, in patients receiving bevacizumab to determine whether remote blood pressure monitoring improves the collection of blood pressure data, identification and management of clinically significant hypertension, and patient satisfaction.

Detailed description: Remote patient monitoring (RPM) technology has the potential to improve the early detection and management of clinically significant hypertension in cancer patients undergoing therapy with bevacizumab, by allowing immediate communication of abnormal measurements to the clinical care team. Additionally, RPM may decrease patients' and caregivers' burdens of ongoing cancer care through an improved user experience compared to usual care.

Criteria for eligibility:
Criteria:
Inclusion Criteria: 1. Participant is a male or female 18 years of age or older. 2. Participant is a current patient at West Michigan Cancer Center/Bronson Cancer Center. 3. Participant is receiving bevacizumab as part of active treatment. 4. Participant is willing and able to provide written informed consent. Exclusion Criteria: 1. Participant is unable to understand English. 2. Participant is hospitalized. 3. Participants are unable to obtain blood pressure readings at home.

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: West Michigan Cancer Center

Address:
City: Kalamazoo
Zip: 49007
Country: United States

Status: Recruiting

Contact:
Last name: Wendi Mitchell

Phone: 269-373-7443
Email: wmitchell@wmcc.org

Contact backup:
Last name: Kathleen Allen

Phone: 269-373-7452
Email: kallen@wmcc.org

Start date: March 11, 2024

Completion date: September 2025

Lead sponsor:
Agency: West Michigan Cancer Center
Agency class: Other

Collaborator:
Agency: Veta Health
Agency class: Other

Source: West Michigan Cancer Center

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06364748

Login to your account

Did you forget your password?